PARP1 and Alzheimer disease: Studies by Yu YZ on Drosophila overexpressing Aβ showed that PARP gene mutation or pharmacological supplementation with NAD+ precursors rescued mitochondrial dysfunction, supporting the idea that PARP polymorphisms and NAD+ bioavailability are linked to Aβ toxicity and AD severity (Yu et al., 2021).